IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 114 filers reported holding IGM BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 3.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,815,891 | -38.5% | 456,993 | -32.0% | 0.00% | 0.0% |
| Q2 2023 | $6,204,304 | +14.7% | 672,189 | +70.8% | 0.00% | 0.0% |
| Q1 2023 | $5,406,882 | +59.8% | 393,514 | +97.8% | 0.00% | 0.0% |
| Q4 2022 | $3,383,731 | -40.3% | 198,926 | -20.2% | 0.00% | 0.0% |
| Q3 2022 | $5,668,000 | +58.4% | 249,269 | +25.5% | 0.00% | 0.0% |
| Q2 2022 | $3,579,000 | -68.7% | 198,554 | -53.6% | 0.00% | -50.0% |
| Q1 2022 | $11,443,000 | -3.3% | 428,087 | +6.1% | 0.00% | 0.0% |
| Q4 2021 | $11,838,000 | -55.7% | 403,624 | -0.7% | 0.00% | -66.7% |
| Q3 2021 | $26,730,000 | -24.0% | 406,480 | -3.9% | 0.01% | -25.0% |
| Q2 2021 | $35,184,000 | -38.0% | 422,883 | -42.9% | 0.01% | -42.9% |
| Q1 2021 | $56,775,000 | +213.2% | 740,310 | +260.6% | 0.01% | +180.0% |
| Q4 2020 | $18,127,000 | +309.0% | 205,318 | +241.9% | 0.01% | +400.0% |
| Q3 2020 | $4,432,000 | -6.1% | 60,054 | -7.1% | 0.00% | 0.0% |
| Q2 2020 | $4,719,000 | +386.0% | 64,645 | +18.2% | 0.00% | – |
| Q3 2019 | $971,000 | – | 54,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,971,542 | $24,812,376 | 1.18% |
| GREAT POINT PARTNERS LLC | 615,317 | $5,137,897 | 0.94% |
| Artal Group S.A. | 2,522,244 | $21,061 | 0.90% |
| Opaleye Management Inc. | 261,000 | $2,179,350 | 0.71% |
| Samsara BioCapital, LLC | 154,664 | $1,291,444 | 0.40% |
| Bruce & Co., Inc. | 120,000 | $1,002,000 | 0.34% |
| Rhenman & Partners Asset Management AB | 200,000 | $1,670,000 | 0.18% |
| Eagle Bay Advisors LLC | 44,635 | $372,702 | 0.17% |
| RA Capital Management | 937,500 | $7,828,125 | 0.15% |
| Baker Brothers Advisors | 3,157,764 | $26,367,329 | 0.15% |